SERI and Carl Zeiss Meditec partner to advance ophthalmic surgery | Healthcare Asia Magazine
, Singapore
Photo from Singhealth website

SERI and Carl Zeiss Meditec partner to advance ophthalmic surgery

The partnership will support different research projects over the next three years.

The Singapore Eye Research Institute (SERI) and Carl Zeiss Meditec AG have entered into a strategic partnership to enhance surgical outcomes in refractive and cataract surgeries.

The collaboration, titled “OPhthalmic Tech Innovation by ZEISS and SERI (OPTIZS)”, is supported by nearly $15m (S$20m) in funding under Singapore's “Research, Innovation and Enterprise 2025 Plan”.

The partnership will support different research projects over the next three years focused on improving clinical outcomes and innovation.

ZEISS and SERI will also work to develop more personalised solutions and improve surgical processes for faster visual rehabilitation and better long-term stability.

Both parties will also explore providing new treatments for presbyopia and improving outcomes for patients with myopia.

S$1 = $0.74

Follow the link for more news on

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!